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Aims: We report the case of a myopic patient who, after intraocular lens transplant in the 
posterior chamber, suffered elevated intraocular pressure due to pigment dispersion, with recur-
rent episodes of blurred vision. The patient was treated with a new surgical technique that can 
avoid potential iridolenticular contact.
Methods: Complete ophthalmologic examination and optical coherence tomography (OCT) 
of the anterior segment were performed.
Results: Contact between the pigmentary epithelium and the iris with an intraocular lens was 
revealed by utrasound biomicroscopy and OCT. In this case, Nd:YAG laser iridotomy and laser 
iridoplasty were not effective for iridolenticular separation and control of the pigment dispersion. 
We propose a new technique: stitches on the surface of the iris to obtain good iridolenticular 
separation and good intraocular pressure control.
Conclusion: Stitches on the iris surface should be considered as optional therapy in pigmentary 
glaucoma secondary to intraocular lens implantation. This surgical technique can avoid potential 
iridolenticular contacts more definitively.
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Introduction
Pigmentary dispersion syndrome secondary to intraocular lens (IOL) implantation 
in the sulcus may be a potential problem with poor response to medical treatment.1–4 
Good results have been obtained with Nd:Yag laser peripheral iridotomy and with 
argon laser iridoplasty.5,6
We report a case with poor response to conventional treatment, in which we devel-
oped a new surgical procedure by suturing the iris surface with prolene stitches in the 
iridolenticular contact zone.
Case report
A 61-years-old woman, surgically treated for right eye cataract 30 months before, 
attended the emergency department for blurred vision after trauma.
Biomicroscopic examination of the anterior segment revealed pseudophakia 
with small slight displacement of the IOL towards the nasal quadrant and marked 
iridopseudophakodonesis, tyndal positive, flare +3, and retrolental pigment without 
evidence of vitreous in the anterior chamber. Gonioscopy showed an open angle with 
pigment deposits from 5 to 7 hours. Right eye intraocular pressure (IOP) was 26 mmHg. 
The posterior segment showed myopic fundus and uncorrected visual acuity was 0.65. 
Left eye biomicroscopic examination showed a posterior chamber IOL, no pigment Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
1264
Canut Jordana et al
dispersion, and a open angle without evident trabecular 
pigmentation.
We observed a good response with timolol 0.5% 
(Timoftol®; MSD Laboratories, Whitehouse Station, NJ) 
and topical prednisolone acetate (Pred-Forte®; Allergan 
Laboratories, Irvine, CA) administered twice daily for two 
weeks. One month later, tyndall was negative and IOP was 
12 mmHg.
Two months later the patient attended our emergency 
department again. We observed a luxated IOL in the   vitreous 
cavity. We therefore decided to perform a vitrectomy, relocation 
of the IOL to the anterior chamber, and extraction since this was 
an IOL with three points of support (Ioltech Stabibag hydro-
philic intraocular lens; Bausch and Lomb, Rochester, NY), and 
scleral-sutured posterior chamber intraocular lens implantation 
(+4.00 D MA60MA Acrysoft®IOL; Alcon Laboratories, Fort 
Worth, TX).
Immediately after intervention we observed satisfactory 
evolution with the IOL in position and IOP of 18 mmHg.
At one and three months after IOL replacement, the 
patient suffered two episodes of intraocular hypertension. 
Both biomicroscopic examinations showed a wide cham-
ber with pigment dispersion in the anterior chamber and 
a cornea with some old endothelial pigment. Intraocular 
pressures of, 30 and 50 mmHg respectively were satis-
factorily treated with a fixed combination of dorzolamide 
and   timoftol (Cosopt®; MSD Laboratories) and topical 
prednisolone acetate (Pred-Forte®; Allergan Laboratories) 
administered twice daily.
At six months after IOL replacement, the patient again 
attended our emergency department, this time complaining 
of blurred vision. Examination revealed abundant pigment 
dispersion throughout the anterior chamber, marked iris 
concavity, and untreated IOP of 14 mmHg (Figure 1). We 
performed a macular ophthalmoscopy and optical coherence 
tomography to (OCT) (Visante®; Carl Zeiss Meditec, Inc., 
Jena, Germany) to look for a cystoid macular edema but no 
macular disorder was found. At this point we considered a 
possible diagnosis of pigment dispersion due to iridolenticu-
lar contact. OCT of the anterior segment showed iris concav-
ity produced by contact between the posterior face of the iris 
and the anterior face of the crystalline lens (Figure 2). This 
finding led to the performance of Nd:YAG laser iridotomy 
which rectified the iris concavity.
At successive check-ups we observed good iridolenticular 
separation in the right eye, permeable iridotomies, anterior 
chamber without celularity, and IOP of 10 mmHg.
Two months after Nd:YAG laser iridectomy, the patient 
reported a new episode of blurred vision. Examination 
showed extensive pigment dispersion in the anterior chamber, 
with right eye IOP of 12 mmHg. After two months of medi-
cal treatment (topical prednisolone acetate and tapered oral 
prednisone) without clinical improvement, we performed 
360° iridoplasty of the peripheral iris, which achieved good 
anatomic resolution but required maintenance therapy with 
antiglaucoma medication and topical nonsteroidal anti-
inflamatory drugs to conserve good visual acuity. Pilocarpine 
eye drops were used previously to check the contractility of 
the iris, finding a poor response.
Twelve months after the iridoplasty, the patient had new 
episodes of blurred vision caused by dispersion of pigment in 
the anterior chamber, which was resolved with   nonsteroidal 
anti-inflammatory drugs and topical beta blockers (Figure 3). 
A repeat OCT of the anterior segment showed iridolenticular 
contact.
Figure 1 Intense pigment dispersion in the anterior chamber and large chamber 
amplitude after intraocular lens replacement.
Figure  2  Photocomposition  of  optical  coherence  tomography  images  of  the 
anterior segment. Note the pronounced iris concavity, the reverse pupillary block, 
and the iridolenticular contact that produced pigment dispersion.Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
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Given the chronic nature of the case and the refusal of 
the patient to undergo IOL removal or repositioning of the 
IOL in the anterior chamber despite good endothelial cell 
count, we decided to perform a more conservative surgery 
consisting of placing four prolene 10/0 stitches (Ethicon Inc, 
Somerville, NJ) on the iris surface to permanently remove 
the iridolenticular contact (Figure 4). The technique consists 
of performing three paracentesis, two of them in each of the 
margins of the area affected by the pigment dispersion, and 
a third at the midpoint. In this way we could access the area 
to be treated by adjusting the different stitches and were thus 
able to lift the flaccid iris, and eliminate the iridolenticular 
contacts.
Six months after placement of the prolene stitches in 
the iris, we observed good tolerance (Figure 5), an absence 
of pigment dispersion in anterior chamber, and a good 
  iridolenticular separation in the OCT (Figure 6). Without 
antiglaucoma medication, uncorrected visual acuity was 
0.65, and an IOP of 17 mmHg.
Discussion
Pigment dispersion syndrome (PDS) is produced when iris 
pigmentary epithelium pigment deposits pass through the 
aqueous humor and are dispersed throughout the anterior seg-
ment. When this dispersion is associated with increased IOP, 
it is called pigmentary glaucoma (PG), which must be taken 
into account on evaluating primary open-angle glaucoma.1
The literature contains cases of PG secondary to IOL 
implantation in the posterior chamber. Among the different 
theories attempting to explain this increase of IOP, the most 
widely accepted proposes that chronic contact between the 
haptics and the posterior face of the iris triggers pigment 
release. This, together with the localization of iris transillumi-
nation defects and increased IOP months after intervention, 
Figure 3 Iris transillumination in slit lamp examination, clearly showing pigmentary 
defect in the areas of chronic rubbing due to iridolenticular and intraocular lens 
haptic contact with the posterior face of the iris.
Figure 4 Details of the placement of prolene stitches in the area of the iris that we   
raised to avoid iridolenticular contact.
Figure 5 six months later. Anterior chamber without pigment dispersion and iris 
prolene stitches well tolerated at 7, 9, and 11 hours.
Figure  6  Detail  showing  iridolenticular  separation  after  prolene  10/0  stitches 
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suggests that the IOL is the most probable cause.2 The 
thickness, size, material, implantation technique, and the 
degree of inclination of the haptics are factors that influence 
changes in the iris.3
Anterior segment optical coherence tomography 
  (AS-OCT) is a high resolution noninvasive technique allow-
ing rapid in vivo evaluation of possible iridolenticular contact, 
as well as visualization of anatomic details such as iris con-
cavity, amplitude, and angle of the anterior chamber.4,5
In order to equalize anterior and posterior chamber 
pressure, many authors propose the use of Nd:YAG laser 
iridotomy, with confirmation of iris flattening by ultrasound 
biomicroscopy. Although most cases prove anatomically 
successful (with restitution of the iris in its anatomic 
position), pressure control is often not achieved. This explains 
why the efficacy of YAG laser iridotomy in pigmentary 
glaucoma is not generally established.6
Considering the physiopathologic mechanisms of 
pigmentary glaucoma and the mechanism of action of argon 
laser iridoplasty (which aims to provoke contraction of the 
peripheral iris and flattening of the peripheral curvature 
using the thermal effect of the laser), we believe that this 
method could be useful for this type of pathology, reducing 
iris concavity and avoiding “reverse pupillary block” and the 
consequent increase of intraocular pressure. However, this 
hypothesis requires prolonged studies with greater numbers 
of patients to determine its possible indication and long-term 
benefits.
Pigment dispersion syndrome secondary to IOL 
implantation in the sulcus and mainly if haptic-optic 
angulation is present as in the case described (MA60MA 
Acrysoft® IOL, Alcon Labs) may prove refractory to medi-
cal treatment and require coadjuvant laser treatment (such 
as iridotomy or iridoplasty), to correct episodes of pigment 
dispersion by minimizing iris-optic and iris-haptic contact.
When the laser treatment is not sufficient to reverse this 
process, different authors propose explants or IOL exchange 
to solve the pigment dispersion.7–10 In our case, the refusal 
of the patient to agree to IOL removal and due to the clearly 
identified iridolenticular contact, we decided to perform 
surgery that involved stitches to the surface of the iris in order 
to lift the iris and separate it from the IOL. As this is a new 
technique, we need more follow-up time and a larger series 
of patients, to confirm this method as an alternative surgical 
treatment when conventional laser (iridotomy and iridoplasty) 
does not resolve the iridolenticular contact.
If the stitches do not suceed, we propose removal of the 
IOL to prevent chronic evolution of pigment loss.
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